Trial Profile
Safety and efficacy of Febuxostat in Hyperuricaemia patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 28 Nov 2015 New trial record